ACTIV: Centralization an Important Part of COVID-19 Fight, But Smaller Players and Community Left Out

ACTIV Centralization an Important Part of COVID-19 Fight, But Smaller Players and Community Left Out

With the COVID-19 pandemic raging, the National Institutes of Health (NIH) announced the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership to develop a coordinated research strategy for prioritizing and accelerating development of what was to be deemed the most promising treatments and vaccines. Backed by the coordination efforts of the Foundation for the National Institutes of Health (FNIH), ACTIV represented the entire U.S. federal government research and health apparatus, including the NIH with its sibling agencies in the Department of Health and Human Services (including BARDA, CDC and FDA). Stakeholders also include other government agencies such as the Department of Defense (DOD) and Department of Veterans Affairs (VA), as well as small role by the European Medicines Agency (EMA) and representatives from academia, philanthropic organizations, and a number of biopharma companies. TrialSite’s review shows that participation is skewed toward just a few federal agencies and a handful of the largest biopharmaceutical companies. Given the magnitude and severity of the public health crisis, the impulse to consolidate and centralize much...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee